Precision Medicine. Engineered at the Molecular Level.
Neologics Bioscience is redefining targeted therapeutics — combining proprietary ligand-receptor science with next-generation delivery mechanisms to address cancers and inflammatory diseases where conventional treatments fail.
A New Class of Targeted Therapeutics
Neologicals is a proprietary molecular targeting platform that engineers high-affinity ligands to selectively bind overexpressed receptors on diseased cells. By coupling these precision ligands with potent therapeutic payloads, Neologicals achieves tumor-selective delivery that spares healthy tissue — dramatically improving the therapeutic index and enabling doses previously impossible with conventional agents.
Mechanism of Action
Programs Advancing Toward the Clinic
"We are not incrementally improving existing therapies. We are building the molecular architecture for a new era of medicine — one where every treatment is as precise as the disease it targets."Neologics Bioscience — Scientific Founding Thesis
Ready to invest in the future of medicine?
We are actively seeking strategic investors and research partners to accelerate our pipeline toward clinical milestones. Connect with our team to explore collaboration opportunities.